4 Top-Ranked Liquid Stocks to Add to Portfolio for Solid Returns
ALHC, AGX, CIEN and WK make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
ALHC - Alignment Healthcare, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$24.83
DETAILS
HIGH:
$30.00
LOW:
$19.00
MEDIAN:
$25.00
CONSENSUS:
$24.83
UPSIDE:
51.87%
Stock News
Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
ORANGE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami, Florida, on Tuesday, June 9, at 10:40 a.m.
Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality
Pharmacy Quality Alliance award underscores sustained excellence in care delivery, medication adherence and pharmacy excellence for seniors Pharmacy Quality Alliance award underscores sustained excellence in care delivery, medication adherence and pharmacy excellence for seniors
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare NASDAQ: ALHC executives said the company remains confident in its second-quarter outlook, citing stable medical cost trends, continued visibility into utilization and opportunities to expand margins as it grows outside California.
Alignment Healthcare, Inc. (ALHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Alignment Healthcare, Inc. (ALHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Alignment Healthcare CEO Adds Chairman Role As Medicare Business Grows
Alignment Healthcare is bolstering its management team, adding the chairman's role to top executive and founder John Kao's duties while promoting several other executives as the company sells more Medicare Advantage plans.
Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation
Founder and CEO John Kao Assumes Additional Role as Chairman of the Board Founder and CEO John Kao Assumes Additional Role as Chairman of the Board
Alignment Healthcare Set to Join S&P SmallCap 600
NEW YORK, May 11, 2026 /PRNewswire/ -- Alignment Healthcare Inc. (NASD: ALHC) will replace Sun Country Airlines Holdings Inc. (NASD: SNCY) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, May 14. S&P SmallCap 600 constituent Allegiant Travel Co. (NASD: ALGT) is acquiring Sun Country Airlines Holdings in a deal expected to close soon, pending final closing conditions.
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
ALHC, AGX, CIEN, and SIMO make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
Can Alignment Healthcare (ALHC) Climb 32.61% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 32.6% in Alignment Healthcare (ALHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Alignment Healthcare, Inc. (ALHC) Q1 2026 Earnings Call Transcript
Alignment Healthcare, Inc. (ALHC) Q1 2026 Earnings Call Transcript
Alignment Healthcare (ALHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alignment Healthcare (ALHC) Q1 Earnings and Revenues Top Estimates
Alignment Healthcare (ALHC) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.05 per share a year ago.
Alignment Healthcare Turns A Profit As Medicare Advantage Costs Ease
Alignment Healthcare Thursday reported net income of more than $11 million as costs of care for older adults in its Medicare Advantage plans eased amid industry struggles with high medical expenses.
Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion
ORANGE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its first quarter ended March 31, 2026.
Alignment Healthcare (ALHC) Price Forecast: Bull Pennant Signals Breakout Potential
Alignment Healthcare approaches earnings with a bullish pennant pattern, rising momentum, and technical signals pointing toward a potential breakout toward prior highs.
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
Here is how Alignment Healthcare (ALHC) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.
PGNY or ALHC: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Progyny (PGNY) and Alignment Healthcare (ALHC). But which of these two stocks is more attractive to value investors?
An Alignment Healthcare (ALHC) Insider Sold 30,000 Shares for $626,000
The President of Alignment Healthcare directly sold 30,000 shares for a transaction value of ~$626,000 on April 15, 2026. This sale represented ~2.83% of the insider's direct holdings, reducing direct ownership to 1,028,813 shares.
SG Americas Securities LLC Grows Position in Alignment Healthcare, Inc. $ALHC
SG Americas Securities LLC boosted its holdings in Alignment Healthcare, Inc. (NASDAQ: ALHC) by 148.5% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 60,390 shares of the company's stock after acquiring an additional 36,084 shares during the quarter. SG Americas Securities LLC's
Price Targets
Alignment Healthcare price target lowered to $22 from $27 at Raymond James
$22.00
(was $18.25)
Raymond James
Alignment Healthcare price target raised to $22 from $21 at UBS
$22.00
(was $19.83)
Jonathan Yong
·
UBS
Alignment Healthcare price target raised to $19 from $18 at Barclays
$19.00
(was $22.54)
Barclays
Alignment Healthcare price target raised to $28 from $22 at Baird
$28.00
(was $22.50)
Robert W. Baird
Alignment Healthcare price target raised to $28 from $21 at KeyBanc
$28.00
(was $23.30)
KeyBanc
Alignment Healthcare price target raised to $21 from $18 at UBS
$21.00
(was $20.92)
UBS
Alignment Healthcare price target raised to $30 from $20 at Piper Sandler
$30.00
(was $21.00)
Jessica Tassan
·
Piper Sandler
Alignment Healthcare Inc (ALHC) PT Raised to $22 at Goldman Sachs
$22.00
(was $16.86)
Scott Fidel
·
Goldman Sachs
Alignment Healthcare price target raised to $18 from $13 at Barclays
$18.00
(was $16.88)
Barclays
Alignment Healthcare price target raised to $18 from $17 at UBS
$18.00
(was $18.53)
Kevin Caliendo
·
UBS
Alignment Healthcare initiated with a Buy at Goldman Sachs
$21.00
(was $17.31)
Goldman Sachs
Alignment Healthcare upgraded to Overweight from Sector Weight at KeyBanc
$21.00
(was $15.58)
Matthew Gillmor
·
KeyBanc
Alignment Healthcare price target raised to $21 from $14 at Piper Sandler
$21.00
(was $15.75)
Piper Sandler
Alignment Healthcare price target raised to $9 from $8 at Barclays
$9.00
(was $15.69)
Barclays
Alignment Healthcare price target raised to $11 from $10 at Baird
$11.00
(was $8.49)
Michael Ha
·
Robert W. Baird
Alignment Healthcare price target raised to $7 from $4.50 at Barclays
$7.00
(was $8.94)
Andrew Mok
·
Barclays
Alignment Healthcare price target raised to $12 from $9 at Stifel
$12.00
(was $9.36)
Craig Jones
·
Stifel Nicolaus
Piper Sandler Upgrades Alignment Healthcare Inc (ALHC) to Overweight
$8.00
(was $6.78)
Jessica Tassan
·
Piper Sandler
Raymond James Upgrades Alignment Healthcare Inc (ALHC) to Strong Buy, 'Following Removal of Star Ratings Overhang'
$10.00
(was $6.62)
John Ransom
·
Raymond James
Analyst Cautiously Optimistic On Alignment Healthcare, Assesses Journey to Profitability Of Medicare Advantage Firm
$9.00
(was $6.29)
Scott Fidel
·
Stephens